Antares Pharma: 3Q Earnings Snapshot

November 5, 2019 GMT

EWING, N.J. (AP) _ Antares Pharma Inc. (ATRS) on Tuesday reported third-quarter net income of $1 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Ewing, New Jersey-based company said it had profit of 1 cent.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 2 cents per share.

The drugmaker posted revenue of $34.3 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $26.4 million.

Antares Pharma expects full-year revenue in the range of $115 million to $120 million.

The company’s shares closed at $3.41. A year ago, they were trading at $3.48.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRS at https://www.zacks.com/ap/ATRS